Company profile: Home Diagnostics
1.1 - Company Overview
Company description
- Provider of blood glucose monitoring systems and disposable supplies for diabetics, developed, manufactured and marketed by Home Diagnostics, offering performance and features comparable to or better than competitors' products, in most cases at a substantially lower price.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Home Diagnostics
Emperra
HQ: Germany
Website
- Description: Provider of GSM- and web-based telemedical solutions for diabetes management, enabling tracking, monitoring and transmission of insulin doses, blood glucose and carbohydrate data. Offers the ESYSTA system with automatic capture of insulin units and blood glucose, plus the ESYSTA Portal and App for authorized healthcare professionals to adjust treatment. Runs the ESYSTA S-T-A-R-T field trial with a smart insulin pen and telemonitoring in statutory health insurance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Emperra company profile →
TypeZero
HQ: United States
Website
- Description: Provider of digital health and personalized medicine focused on the treatment and management of diabetes, leveraging more than 10 years of clinical trials, research, and innovation to develop the inControl Diabetes Management Platform to improve and simplify the lives of people with diabetes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TypeZero company profile →
Endogenex
HQ: United States
Website
- Description: Provider of an investigational endoscopic procedure (ReCET) that uses pulsed electric fields to regenerate signaling cells in the duodenum, aiming to improve blood glucose control in patients with type 2 diabetes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Endogenex company profile →
Osler Diagnostics
HQ: United Kingdom
Website
- Description: Provider of portable, low-cost, quick, and easy-to-use lab-quality diagnostics, featuring the Osler Origin 'portable lab' for a wide range of tests across healthcare settings. Offers lab-in-your-hand technology with microfluidic sample preparation and electrochemical biosensing, HemaTap sample addition for simplified cartridges, and a comprehensive test menu.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Osler Diagnostics company profile →
Lifecare
HQ: Norway
Website
- Description: Provider of miniaturized, implantable glucose sensors and nano biosensing solutions. Offerings include Sencell, a real-time glucose sensor measuring osmotic pressure, lasting at least six months and transmitting data wirelessly to smart devices; NanoBioSensors for high-resolution diagnostics in live tissue; and Lifecare Veterinary for continuous animal glucose monitoring.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lifecare company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Home Diagnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Home Diagnostics
2.2 - Growth funds investing in similar companies to Home Diagnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Home Diagnostics
4.2 - Public trading comparable groups for Home Diagnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →